收藏切换
Advances in Drug Delivery Systems Based on Hepatic Macrophage Functions
收藏切换
Wenjing YAN, Weigen LU*, Xiaohong LU, Jun HE
Chinese Journal of Pharmaceuticals | 2026, 57(8) : 877 - 885
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2026, 57(8): 877-885
• Perspective & Review •
Advances in Drug Delivery Systems Based on Hepatic Macrophage Functions
Full
Wenjing YAN, Weigen LU*, Xiaohong LU, Jun HE
Affiliations
  • China State Institute of Pharmaceutical Industry, Shanghai 201203
Published: 2026-08-10 doi: 10.16522/j.cnki.cjph.2026.08.001
Outline
收藏切换

The onset and progression of liver diseases are generally accompanied by immune-inflammatory dysregulation. Hepatic macrophages play a central role in amplifying pro-inflammatory responses, regulating oxidative stress, promoting fibrotic remodeling, and shaping the tumor immune microenvironment, rendering them important targets for precision therapy in liver diseases. In recent years, drug delivery systems targeting hepatic macrophages have been continuously developed, with strategies expanding from passive accumulation strategies to multi-tiered systems featuring ligand recognition, microenvironment-responsive delivery, biomimetic camouflage, and in situ cellular reprogramming. From the perspective of drug delivery, this review summarizes representative strategies,including lipid nanoparticles, polymeric and stimuli-responsive systems, inorganic/hybrid nanomaterials, extracellular vesicles, and cell membrane-biomimetic systems, with a focus on analyzing their applicability and limitations in different pathological contexts, such as acute liver injury, metabolic liver disease, liver fibrosis, and hepatocellular carcinoma. Furthermore, key issues including hepatic macrophage subset heterogeneity, intracellular delivery efficiency, long-term safety, and industrial feasibility are discussed, along with a clinical translation prospect in this field, aiming to provide a reference for precision therapy of liver diseases.

hepatic macrophage  /  targeted delivery  /  drug delivery system  /  immuno-inflammatory regulation  /  liver disease  /  research progress
颜文静, 陆伟根, 芦晓红, 何军. 基于肝巨噬细胞功能的药物递送系统研究进展. 中国医药工业杂志, 2026 , 57 (8) : 877 -885 . DOI: 10.16522/j.cnki.cjph.2026.08.001
Wenjing YAN, Weigen LU, Xiaohong LU, Jun HE. Advances in Drug Delivery Systems Based on Hepatic Macrophage Functions[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (8) : 877 -885 . DOI: 10.16522/j.cnki.cjph.2026.08.001
Year 2026 volume 57 Issue 8
171
44
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2026.08.001
  • Receive Date:2026-01-30
  • Online Date:2026-11-05
  • Published:2026-08-10
Article Data
Affiliations
History
  • Received:2026-01-30
Funding
Affiliations
    China State Institute of Pharmaceutical Industry, Shanghai 201203
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.08.001
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT